PKM and hepatocellular carcinoma: Recent evidence shows that HULC upregulates CyclinD1 through the miR-675-PKM2 pathway, promotes the growth of human hepatoma cells through autophagy [24], and accelerates liver cancer by inhibiting PTEN via autophagy cooperation with miR-15a [25].